Metraipolis › archive › dc_847ff2d18f24
A multimodal biological margin risk index predicts recurrence after neoadjuvant immunochemotherapy in head and neck squamous cell carcinoma — Europe PMC PMID:41727460
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41727460
- DOI
- 10.3389/fimmu.2026.1740643
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T01:56:35.223Z
- SHA-256 of the archived text
07d5b29aed4afbdfa8dfc6ea1b692786b2265acadbb4fe367bb4c63eab0b6d05- Stable URL of this page
https://metraipolis.com/documento/dc_847ff2d18f24
How to cite
A multimodal biological margin risk index predicts recurrence after neoadjuvant immunochemotherapy in head and neck squamous cell carcinoma — Europe PMC PMID:41727460 — Europe PMC (en), https://europepmc.org/article/MED/41727460 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_847ff2d18f24 (Metraipolis archive dc_847ff2d18f24, sha256 07d5b29aed4afbdfa8dfc6ea1b692786b2265acadbb4fe367bb4c63eab0b6d05)
BibTeX
@misc{dc847ff2d18f24,
title = {A multimodal biological margin risk index predicts recurrence after neoadjuvant immunochemotherapy in head and neck squamous cell carcinoma — Europe PMC PMID:41727460},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41727460},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_847ff2d18f24; sha256 07d5b29aed4afbdfa8dfc6ea1b692786b2265acadbb4fe367bb4c63eab0b6d05},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727460. Agents can read the archived copy with the MCP tool read_document.